168 related articles for article (PubMed ID: 9071516)
1. Levonorgestrel concentrations during use of levonorgestrel rod (LNG ROD) implants.
Sivin I; Lähteenmäki P; Ranta S; Darney P; Klaisle C; Wan L; Mishell DR; Lacarra M; Viegas OA; Bilhareus P; Koetsawang S; Piya-Anant M; Diaz S; Pavez M; Alvarez F; Brache V; LaGuardia K; Nash H; Stern J
Contraception; 1997 Feb; 55(2):81-5. PubMed ID: 9071516
[TBL] [Abstract][Full Text] [Related]
2. First week drug concentrations in women with levonorgestrel rod or Norplant capsule implants.
Sivin I; Lähteenmäki P; Mishell DR; Alvarez F; Diaz S; Ranta S; Grozinger C; Lacarra M; Brache V; Pavez M; Nash H; Stern J
Contraception; 1997 Nov; 56(5):317-21. PubMed ID: 9437561
[TBL] [Abstract][Full Text] [Related]
3. The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study.
Sivin I; Campodonico I; Kiriwat O; Holma P; Diaz S; Wan L; Biswas A; Viegas O; el din Abdalla K; Anant MP; Pavez M; Stern J
Hum Reprod; 1998 Dec; 13(12):3371-8. PubMed ID: 9886517
[TBL] [Abstract][Full Text] [Related]
4. Contraception with two levonorgestrel rod implants. A 5-year study in the United States and Dominican Republic.
Sivin I; Alvarez F; Mishell DR; Darney P; Wan L; Brache V; Lacarra M; Klaisle C; Stern J
Contraception; 1998 Nov; 58(5):275-82. PubMed ID: 9883382
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Norplant implants among Thai women in Bangkok.
Chompootaweep S; Kochagarn E; Sirisumpan S; Tang-usaha J; Theppitaksak B; Dusitsin N
Contraception; 1996 Jan; 53(1):33-6. PubMed ID: 8631187
[TBL] [Abstract][Full Text] [Related]
6. Clinical performance of a new two-rod levonorgestrel contraceptive implant: a three-year randomized study with Norplant implants as controls.
Sivin I; Viegas O; Campodonico I; Diaz S; Pavez M; Wan L; Koetsawang S; Kiriwat O; Anant MP; Holma P; el din Abdalla K; Stern J
Contraception; 1997 Feb; 55(2):73-80. PubMed ID: 9071515
[TBL] [Abstract][Full Text] [Related]
7. Levonorgestrel concentrations during 7 years of continuous use of Jadelle contraceptive implants.
Sivin I; Wan L; Ranta S; Alvarez F; Brache V; Mishell DR; Darney P; Biswas A; Diaz S; Kiriwat O; Anant MP; Klaisle C; Pavez M; Schechter J
Contraception; 2001 Jul; 64(1):43-9. PubMed ID: 11535213
[TBL] [Abstract][Full Text] [Related]
8. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
Sivin I; Stern J; Diaz S; Pavéz M; Alvarez F; Brache V; Mishell DR; Lacarra M; McCarthy T; Holma P
Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
[TBL] [Abstract][Full Text] [Related]
9. Acceptability of Norplant-2 rods as a method of family planning.
Singh K; Viegas OA; Ratnam SS
Contraception; 1992 May; 45(5):453-61. PubMed ID: 1623717
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of levonorgestrel and free levonorgestrel index in women using NORPLANT implants or two covered rods (NORPLANT-2).
Olsson SE; Odlind V; Johansson ED; Nordström ML
Contraception; 1987 Mar; 35(3):215-28. PubMed ID: 3111784
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and continuation rates of Norplant in Pakistan.
Rehan N; Inayatullah A; Chaudhary I
Contraception; 1999 Jul; 60(1):39-43. PubMed ID: 10549451
[TBL] [Abstract][Full Text] [Related]
12. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
[TBL] [Abstract][Full Text] [Related]
13. Sex hormone binding globulin and free levonorgestrel index in the first week after insertion of Norplant implants.
Alvarez F; Brache V; Tejada AS; Cochon L; Faundes A
Contraception; 1998 Oct; 58(4):211-4. PubMed ID: 9866001
[TBL] [Abstract][Full Text] [Related]
14. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
[TBL] [Abstract][Full Text] [Related]
15. Insulin sensitivity is unaltered by the use of the Norplant subdermal implant contraceptive.
Koopersmith TB; Lobo RA
Contraception; 1995 Mar; 51(3):197-200. PubMed ID: 7621688
[TBL] [Abstract][Full Text] [Related]
16. Experience of Thai women in Bangkok with Norplant-2 implants.
Chompootaweep S; Kochagarn E; Tang-Usaha J; Theppitaksak B; Dusitsin N
Contraception; 1998 Oct; 58(4):221-5. PubMed ID: 9866003
[TBL] [Abstract][Full Text] [Related]
17. Effects of levonorgestrel-releasing subdermal contraceptive implants on bone density and bone metabolism.
Di X; Li Y; Zhang C; Jiang J; Gu S
Contraception; 1999 Sep; 60(3):161-6. PubMed ID: 10640160
[TBL] [Abstract][Full Text] [Related]
18. Assessing the acceptability of Norplant contraceptive in four patient populations.
Dugoff L; Jones OW; Allen-Davis J; Hurst BS; Schlaff WD
Contraception; 1995 Jul; 52(1):45-9. PubMed ID: 8521714
[TBL] [Abstract][Full Text] [Related]
19. Timing of onset of contraceptive effectiveness in Norplant implant users. Part I. Changes in cervical mucus.
Dunson TR; Blumenthal PD; Alvarez F; Brache V; Cochon L; Dalberth B; Glover L; Remsburg R; Vu K; Katz D
Fertil Steril; 1998 Feb; 69(2):258-66. PubMed ID: 9496339
[TBL] [Abstract][Full Text] [Related]
20. A 5-year clinical evaluation of Norplant implants in Senegal.
Ba MG; Moreau JC; Sokal D; Dunson R; Dao B; Kouedou D; Diadhiou F
Contraception; 1999 Jun; 59(6):377-81. PubMed ID: 10518232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
